These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23205435)

  • 1. [109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Translational research and evidence-based medicine (EBM) in internal medicine in Japan, EBM; 1) How to understand the results of randomized controlled trials for primary prevention of cardiovascular events in patients with diabetes mellitus: Lesson from the JPAD trial].
    Saito Y; Okada S; Ogawa H; Soejima H; Morimoto T; Sakuma M;
    Nihon Naika Gakkai Zasshi; 2012 Sep; 101(9):2563-70. PubMed ID: 23205435
    [No Abstract]   [Full Text] [Related]  

  • 2. [109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Translational research and evidence-based medicine (EBM) in internal medicine in Japan, EBM: 2) Pursuit for establishing evidence-based medicine in the field of cardiovascular disease in Japan].
    Kimura T
    Nihon Naika Gakkai Zasshi; 2012 Sep; 101(9):2571-8. PubMed ID: 23205436
    [No Abstract]   [Full Text] [Related]  

  • 3. [109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Translational research and evidence-based medicine (EBM) in internal medicine in Japan, EBM; 3) Can an outstanding clinical trial predict a future?].
    Asaka M
    Nihon Naika Gakkai Zasshi; 2012 Sep; 101(9):2579-84. PubMed ID: 23205437
    [No Abstract]   [Full Text] [Related]  

  • 4. [109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Translational research and evidence-based medicine (EBM) in internal medicine in Japan, translational research; 2) Treatment of cardiovascular diseases by intervening autonomic nerves: its basic and translational research].
    Sugimachi M; Sunagawa K
    Nihon Naika Gakkai Zasshi; 2012 Sep; 101(9):2539-43. PubMed ID: 23205432
    [No Abstract]   [Full Text] [Related]  

  • 5. [109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Translational research and evidence-based medicine (EBM) in internal medicine in Japan; introduction].
    Ito S; Kimura T
    Nihon Naika Gakkai Zasshi; 2012 Sep; 101(9):2532. PubMed ID: 23205430
    [No Abstract]   [Full Text] [Related]  

  • 6. [109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Translational research and evidence-based medicine (EBM) in internal medicine in Japan, translational research; 1) Translational research on neurodegenerative diseases].
    Katsuno M; Banno H; Suzuki K; Hashizume A; Adachi H; Tanaka F; Sobue G
    Nihon Naika Gakkai Zasshi; 2012 Sep; 101(9):2533-8. PubMed ID: 23205431
    [No Abstract]   [Full Text] [Related]  

  • 7. [109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Translational research and evidence-based medicine (EBM) in internal medicine in Japan, translational research; 4) Translational research of endocrinology and metabolism].
    Hosoda K; Yasoda A; Ebihara K; Kuwahara K; Mukouyama M; Nakao K
    Nihon Naika Gakkai Zasshi; 2012 Sep; 101(9):2552-62. PubMed ID: 23205434
    [No Abstract]   [Full Text] [Related]  

  • 8. [109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 2. Translational research and evidence-based medicine (EBM) in internal medicine in Japan, translational research; 3) Development of therapy for amyotrophic lateral sclerosis and distal myopathy].
    Aoki M
    Nihon Naika Gakkai Zasshi; 2012 Sep; 101(9):2544-51. PubMed ID: 23205433
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin for the primary prevention of cardiovascular events in patients with peripheral artery disease or diabetes mellitus. Analyses from the JPAD, POPADAD and AAA trials.
    Soejima H; Morimoto T; Saito Y; Ogawa H
    Thromb Haemost; 2010 Dec; 104(6):1085-8. PubMed ID: 20941462
    [No Abstract]   [Full Text] [Related]  

  • 10. [112th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Emerging Comorbidities of Diabetes Mellitus: Drug Therapy of Diabetes Mellitus to Prevent Complications].
    Inagaki N
    Nihon Naika Gakkai Zasshi; 2015 Sep; 104(9):1912-6. PubMed ID: 30160897
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical evidence for Japanese population based on prospective studies--linking clinical trials and clinical practice.
    Ogawa H; Kojima S
    J Cardiol; 2009 Oct; 54(2):171-82. PubMed ID: 19782253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial.
    Saito Y; Okada S; Ogawa H; Soejima H; Sakuma M; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Morimoto T;
    Circulation; 2017 Feb; 135(7):659-670. PubMed ID: 27881565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low-dose aspirin on primary prevention of cardiovascular events in Japanese diabetic patients at high risk.
    Okada S; Morimoto T; Ogawa H; Sakuma M; Soejima H; Nakayama M; Sugiyama S; Jinnouchi H; Waki M; Doi N; Horii M; Kawata H; Somekawa S; Soeda T; Uemura S; Saito Y;
    Circ J; 2013; 77(12):3023-8. PubMed ID: 24042256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.
    Gilpin VL; ; ;
    J Vasc Nurs; 2010 Dec; 28(4):154-5. PubMed ID: 21074118
    [No Abstract]   [Full Text] [Related]  

  • 15. [Trial of pioglitazone for the secondary prevention of cardiovascular events in patients with diabetes mellitus type 2: insufficient evidence].
    Veneman TF
    Ned Tijdschr Geneeskd; 2006 Apr; 150(16):931-2; author reply 932-3. PubMed ID: 16686096
    [No Abstract]   [Full Text] [Related]  

  • 16. [Trial of pioglitazone for the secondary prevention of cardiovascular events in patients with diabetes mellitus type 2: insufficient evidence].
    Heine RJ
    Ned Tijdschr Geneeskd; 2006 Apr; 150(16):930-1; author reply 932-3. PubMed ID: 16686095
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis.
    Stavrakis S; Stoner JA; Azar M; Wayangankar S; Thadani U
    Am J Med Sci; 2011 Jan; 341(1):1-9. PubMed ID: 21191260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
    Schnell O; Erbach M; Hummel M
    Diab Vasc Dis Res; 2012 Oct; 9(4):245-55. PubMed ID: 22508698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: Benefit or risk?
    Leggio M; Bendini MG; Caldarone E; Lombardi M; Severi P; D'Emidio S; Stavri DC; Armeni M; Bravi V; Mazza A
    Diabetes Metab; 2018 Jun; 44(3):217-225. PubMed ID: 29257747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.